News, people, new membranes, mergers and acquisition Sulzer has signed an agreement for the acquisition of Kuhni Ltd, Allschwil, Switzerland Winterthur, March 27, 2009 Sulzer has signed an agreement for the acquisition of the privately owned Kühni Ltd, Allschwil, Switzerland, a specialist for thermal separation processes. Kühni achieved sales of CHF 37 million in 2008 and employs over 80 people.   more Hyflux Ltd acquires remaining interest in Hyflux CEPAration BV Jan. 20, 2009 Hyflux Ltd of Singapore, acquired the remaining 30% stake, which it did not already own in, Hyflux CEPAration BV, a Helmond-based developer and manufacturer of ceramic membranes, for 0.818 mil euros (1.600 Singapore dollars/$ 1.069 mil US) in cash.   more Sulzer signed Contract for the acquisition of Kuhni Ltd Winterthur, March 27, 2009 Sulzer has signed an agreement for the acquisition of the privately owned Kühni Ltd, Allschwil, Switzerland, a specialist for thermal separation processes. Kühni achieved sales of CHF 37 million in 2008 and employs over 80 people. As an expert in thermal, diffusional and membrane separation technology for the separation and purification of aqueous and organic mixtures, Kühni provides process engineering services, designs, manufactures and supplies process equipment and turn-key modular plants to the process industry with a focus on the pharmaceutical and fine chemical industry. Located in Allschwil/Basel, Switzerland, Kühni is also present in the USA and active in Asia. The group employs over 80 people and reported consolidated sales of CHF 37 million in 2008. Closing is expected to take place in the second quarter of 2009, after the fulfillment of all conditions of the transaction. Sulzer Chemtech will establish a new process technology unit by combining its current offering of process solutions for columns, membranes and crystallization with the activities of Kühni. This combination will create synergies and will in particular strengthen Kühni’s activities in Asia. The existing location of Kühni in Allschwil will become the center of excellence for process technology. All Kühni staff including the management team will be retained after the acquisition. The transaction resolves the succession of the present CEO and owner and ensures a smooth transition and continuing success. Sulzer Chemtech has a leading position in the fields of separation columns, static mixing, as well as two-component mixing and dispensing systems. With locations for sales, engineering, production and customer service, Sulzer Chemtech maintains a worldwide presence for its clients in the oil and gas, hydrocarbon processing and other industrial markets. Sulzer was founded in 1834 in Winterthur, Switzerland, and today is active in machinery and equipment manufacturing and surface engineering at over 120 locations worldwide. The divisions are global leaders in their respective customer segments, which include the oil and gas, hydrocarbon processing, power generation, pulp and paper, aviation and automotive industries. download the press release    www.sulzer.com Hyflux Ltd acquires remaining interest in Hyflux CEPAration BV Singapore, Jan. 20, 2009 Hyflux Ltd ("Hyflux") is pleased to announce that it has increased the shareholding in its Netherlands incorporated subsidiary, Hyflux CEPAration B.V. ("HCBV"), upon acquiring the remaining 30% of HCBV’s issued shares from CEramic PArtners B.V. and Wafilin B.V., for approximately SGD 1,600,000. This acquisition was completed on 19 January 2009, upon which HCBV became a wholly owned subsidiary of Hyflux. HCBV is a leader in the area of ceramic membranes technology. The company’s InoCep™ membrane was a Category Winner in the Aquatech Innovation Awards in 2006, providing for effective and environmentally friendly separation solutions to a wide range of non water industries. HCBV and the other CEPAration subsidiaries in Europe are part of Hyflux's global platform in membrane technologies development and application. Commenting on the development, Ms Olivia Lum, Group CEO and President of Hyflux said: "This transaction demonstrates Hyflux’s continuous commitment in the research of membrane technologies, its application and commercialisation; and further strengthens Hyflux’s existing R&D capabilities and builds upon its leadership position as the largest R&D centre for membrane and material sciences in Asia outside of Japan." The acquisition price is funded by internal source and is not expected to have any material impact on the consolidated net tangible assets and earnings per share of Hyflux for the current year. None of the directors and substantial shareholders of Hyflux have any interest, direct or indirect in the purchase transaction. more info

news     neu     actu Your Press Release Are you lauching a new product ? Did your company built a new plant ? delivered an important piece of equipment? agreed to a distribution agreement ? Publish your article, post your news release... Your Diary    conferences,    meetings, trainings, workshops,    exhibitions Projets    new enquiries, Press archive   2009   08   07   06   05